Literature DB >> 19360314

Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.

Igor Vareniuk1, Pal Pacher, Ivan A Pavlov, Viktor R Drel, Irina G Obrosova.   

Abstract

Evidence for the important role of the potent oxidant peroxynitrite in peripheral diabetic neuropathy and neuropathic pain is emerging. This study evaluated the contribution of neuronal nitric oxide synthase (nNOS) to diabetes-induced nitrosative stress in peripheral nerve and dorsal root ganglia, and peripheral nerve dysfunction and degeneration. Control and nNOS-/- mice were made diabetic with streptozotocin, and maintained for 6 weeks. Peroxynitrite injury was assessed by nitrotyrosine and poly(ADP-ribose) immunoreactivities. Peripheral diabetic neuropathy was evaluated by measurements of sciatic motor and hind-limb digital sensory nerve conduction velocities, thermal algesia, tactile allodynia, and intraepidermal nerve fiber density. Control nNOS-/- mice displayed normal motor nerve conduction velocity and thermal response latency, whereas sensory nerve conduction velocity was slightly lower compared with non-diabetic wild-type mice, and tactile response threshold and intraepidermal nerve fiber density were reduced by 47 and 38%, respectively. Both diabetic wild-type and nNOS-/- mice displayed enhanced nitrosative stress in peripheral nerve. In contrast to diabetic wild-type mice, diabetic nNOS-/- mice had near normal nitrotyrosine and poly(ADP-ribose) immunofluorescence in dorsal root ganglia. Both diabetic wild-type and nNOS-/- mice developed motor and sensory nerve conduction velocity deficits and thermal hypoalgesia although nNOS gene deficiency slightly reduced severity of the three disorders. Tactile response thresholds were similarly decreased in control and diabetic nNOS-/- mice compared with non-diabetic wild-type mice. Intraepidermal nerve fiber density was lower by 27% in diabetic nNOS-/- mice compared with the corresponding non-diabetic group, and by 20% in diabetic nNOS-/- mice compared with diabetic wild-type mice. In conclusion, nNOS is required for maintaining the normal peripheral nerve function and small sensory nerve fibre innervation. nNOS gene deficiency does not protect from development of nerve conduction deficit, sensory neuropathy and intraepidermal nerve fiber loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19360314      PMCID: PMC2756471          DOI: 10.3892/ijmm_00000166

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  57 in total

1.  Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice.

Authors:  Matthew R Nangle; Mary A Cotter; Norman E Cameron
Journal:  Eur J Pharmacol       Date:  2004-10-11       Impact factor: 4.432

Review 2.  Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

Authors:  N E Cameron; S E Eaton; M A Cotter; S Tesfaye
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

Review 3.  Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention.

Authors:  László Virág; Eva Szabó; Pál Gergely; Csaba Szabó
Journal:  Toxicol Lett       Date:  2003-04-11       Impact factor: 4.372

4.  The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes.

Authors:  Pal Pacher; Lucas Liaudet; Francisco Garcia Soriano; Jon G Mabley; Eva Szabó; Csaba Szabó
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

5.  Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.

Authors:  Ling Zheng; Csaba Szabó; Timothy S Kern
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

6.  Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats.

Authors:  M A Cotter; N E Cameron
Journal:  Life Sci       Date:  2003-08-22       Impact factor: 5.037

7.  Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.

Authors:  Irina G Obrosova; Alexander G Minchenko; Robert N Frank; Gail M Seigel; Zsuzsanna Zsengeller; Pál Pacher; Martin J Stevens; Csaba Szabó
Journal:  Int J Mol Med       Date:  2004-07       Impact factor: 4.101

8.  Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.

Authors:  Mary A Cotter; Karin Ekberg; John Wahren; Norman E Cameron
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

9.  Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.

Authors:  Irina G Obrosova; Fei Li; Omorodola I Abatan; Mark A Forsell; Katalin Komjáti; Pal Pacher; Csaba Szabó; Martin J Stevens
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

10.  Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.

Authors:  F Li; C Szabó; P Pacher; G J Southan; O I Abatan; T Charniauskaya; M J Stevens; I G Obrosova
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

View more
  20 in total

1.  Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

2.  Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes.

Authors:  Abd A Tahrani; Asad Ali; Neil T Raymond; Safia Begum; Kiran Dubb; Shanaz Mughal; Biju Jose; Milan K Piya; Anthony H Barnett; Martin J Stevens
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

3.  Neuron-astrocyte signaling network in spinal cord dorsal horn mediates painful neuropathy of type 2 diabetes.

Authors:  Jacqueline R Dauch; Brandon M Yanik; Wilson Hsieh; Sang Su Oh; Hsinlin T Cheng
Journal:  Glia       Date:  2012-05-09       Impact factor: 7.452

Review 4.  Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?

Authors:  Kevin L Farmer; Chengyuan Li; Rick T Dobrowsky
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

5.  Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies.

Authors:  Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Igor Vareniuk; Martin J Stevens; Jerry L Nadler; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2010-06-22       Impact factor: 7.376

6.  The three isoforms of nitric oxide synthase distinctively affect mouse nocifensive behavior.

Authors:  Julia Finkel; Virginia Guptill; Alfia Khaibullina; Nicholas Spornick; Olavo Vasconcelos; David J Liewehr; Seth M Steinberg; Zenaide M N Quezado
Journal:  Nitric Oxide       Date:  2011-12-17       Impact factor: 4.427

Review 7.  Peroxynitrite-driven mechanisms in diabetes and insulin resistance - the latest advances.

Authors:  K Stadler
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 8.  Oxidative and nitrative stress in neurodegeneration.

Authors:  Catherine A Cobb; Marsha P Cole
Journal:  Neurobiol Dis       Date:  2015-05-27       Impact factor: 5.996

Review 9.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

Review 10.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.